World News | Hong Kong Approves Bharat Biotech's Covaxin

Hong Kong [Hong Kong], November 10 (ANI): Hong Kong has recognised Hyderabad-based pharmaceutical firm Bharat Biotech's Covaxin on its approved COVID-19 vaccine list.

With this, as many as 96 countries have recognised Covaxin and Covishield. Both of these COVID-19 vaccines have also received emergency use listing (EUL) from the World Health Organisation (WHO).

Also Read | Philippines: Iloilo First City in Asia Where Property Sold For Cryptocurrency.

Canada, the US, Australia, Spain, the United Kingdom, France, Germany, Belgium, Russia, and Switzerland, are among the 96 nations who have given approval of both India manufactured vaccines.

Last week, the WHO granted approval for Emergency Use Listing of Covaxin and said that the Bharat Biotech's vaccine was found to have 78 per cent efficacy against the COVID-19 of any severity, 14 or more days after the second dose.

Also Read | Priyanka Chopra Jonas Congratulates Nobel Laureate Malala Yousafzai On Her Wedding! (View Post).

"Covaxin was found to have 78 per cent efficacy against COVID-19 of any severity, 14 or more days after the second dose, and is extremely suitable for low and middle-income countries due to easy storage requirements," WHO had said.

The UN health body's emergency use listing procedure assess the vaccine under the procedure based on the review of data on quality, safety, efficacy, a risk management plan and suitability in low- and middle-income countries. (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)